| 1. | Suputtitada A. Spasticity : Physiology of normal muscle and pathophysioloy of spasticity.J Thai Rehabil 1999;8(3):230-40. |
| 2. | Nathan P. Some comments on spasticity and rigidity. In : Desmedt JE,ed.
New developments in electromyography and clinical neurophysiology. Basel:Karga,
1973:13-4. |
| 3. | Lance JW. Pyramidal and extrapyramidal disorders.In: Shahani DT,ed. Electromyography in CNS disorders. Boston:Butterworth,1984:1-19. |
| 4. | Mayer NH. Clinicophysiologic concepts of spsticity and motor dysfunction
in
adults with an upper motoneuron lesion. Muscle Nerve1997;20(suppl 6) :S1-S13. |
| 5. | Hoefer PFA, Putnam TJ. Action potentials of muscles in spastic conditions
Arch
Neurol Psychiat 1940;43:1-22. |
| 6. | Mayer N. Esquenazi A, Childrens MK. Common pattern of clinical motor
dysfunction. Muscle Nerve 1997; 20 ( suppl 6 ) : S21-S35. |
| 7. | Esquenazi A, Mayer N. New advances in the management of spasticity&
muscle overactivity. CD-ROM by Professional Postgraduate Services, a division
of
Physicians World Communication Group. May 2000 |
| 8. | Little JW, Massagi TL. Spasticity and associated abnormalities of muscle
tone.
In: Delisa JA, ed. Rehabilitation medicine : principle and practice. 2nd ed. Philadephia : JB lippincott, 1993 : 668-76. |
| 9. | Suputtitada A. New techniques in the treatment of spasticity. Chula
Med J 1999;
43(2):69-87. |
| 10. | Gormley MF,O'Brien CF, Yablon SA. A clinical overview of treatment
decisions in
the management of spasticity. Muscle Nerve 1997;20(suppl 6):S14-S20. |
| 11. | Little JW, Merritt JL. Spasticity and associated abnormalities of muscle
tone.In
:Delisa JA, ed. Rehabilitation Medicine : Principles and Practice. Philadelphia :Lippincott, 1988 ; 565-84. |
| 12. | Keeman MAE, Eufrocina ST, Stone L, Gersten LM. Percutaneous phenol
block
of the musculocutaneous nerve to control elbow flexor spasticity. J Hand Surg 1990 ; 15A (2) : 340 -46. |
| 13. | Young RR. Physiologic and pharmacologic approaches to spasticity . Neurologic clinics 1987 ; 5 (4) : 529-39. |
| 14. | Award EA, Dykstra D. Treatment of spasticity by neurolysis. In: Kottke
FJ, Stillwell
GK, Lehmann JF,eds. Krusen's Handbook of Physical Medicine and Rehabilitation. 4 th ed. Philadelphia; WB Saunder,1990 : 1154-61. |
| 15. | Brin MF. Botulinum toxin: Chenistry, Pharmacology, Toxicity, and Immunology.
Muscle Nerve 1997;20(Suppl 6): S146-167. |
| 16. | Das TK, Park DM. Botulinum toxin in treating spasticity. By J Clin
Pharmacol
1989 ; 43 : 401-3. |
| 17. | Hesse S, Friedrich H, Domasch C, Mauritz KH. Botulinum toxin
therapy for
upper limb flexor spasticity : preliminary results. J of Rehabil Sci 1992 1992;5:98-101. |
| 18. | Koman LA, Mooney JF, Smith B,et al. Management of cerebral palsy with
botulinum A toxin : Preliminary investigation. J Ped orthopedics 1993;
13:
489-95. |
| 19. | Cosgrove AP, Graham HK. Botulinum toxin A in the management of children
with
cerebral palsy . Bone and joint Surg (BR). 1992;74-B ( Suppl II) L 135-6 |
| 20. | Calderon-gongalez R, Calderon- sepulveda R F. Patho physiology of spasticity and the role of botulinum toxin in its treatment . Acta Neuropediatr 1994; 44-57 |
| 21. | Snow BJ, Tsui JKC, Bhatt MH,et al. Treatment of spasticity with botulinum toxin : A double-bind study. Ann Neurol 1990; 28:512-5. |
| 22. | Hesse S, Lucke D, Malezic M.et al. Botulinum toxin treatment for lower
limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg
Psychiat
1994;57:1321-4. |
| 23. | Viriyavejakul A, Vachalathiti R, Poungvarin N. Botulinum treatment for post-stroke Spasticity : Low dose regime. J Med Assoc Thai 1998;81(6):413-22. |
| 24. | Suputtitada A. Managing Spasticity in Pediatric Cerebral Palsy Using
a Very Low
Dose of Botulinum Toxin Type A; Preliminary Report .Am J Phy Med Rehabil 2000;79:320-6. |
| 25. | Suputtitada A. Local botulinum toxin injection in the treatment of
spastic toes.
Abstract. The 6th International Congress of Parkinson's disease and Movement Disorders, Barcelona, Spain, 11-15 June 2000 |
| 26. | Nathan PW. Chemical rhizotomy for relieve of spasticity in ambulant
patients. Br
Med J 1965;1(5442):1096-100. |
| 27. | Putnam TJ, Hampton AO. A Technique of injection in the gasserian
ganglion
under roentgenographic control. Arch Neurol Psychiat 1936 ; 35(1):92-8. |
| 28. | Tamura K. Histopathological studies of the spinal cord following subarachnoid
block using phenol,clinical and experimental studies. Masui Jpn J Anesthesiol 1975; 24(7): 681-94. |
| 29. | Khalili AA, Harmel MN, Forster S, Benton JG. Management of spasticity
by
selective peripheral nerve block with dilute phenol solutions in clinical rehabilitation. Arch Phys Med Rehabil 1964;45(10):513-9. |
| 30. | Khalili AA,Betts HB. Peripheral nerve block with phenol in the management
of
spasticity: Indication and complications. JAMA 1967;48(2):97-9. |
| 31. | Garland DE,Lilling M, Keenan MA. Percutaneous phenol blocks to motor
points
of spastic forearm muscles in head-injured adults. Arch Phys Med Rehabil 1984;65(5):243-5. |
| 32. | Keenan MA, Botte MJ. Technique of percutaneous phenol block of the
recurrent
motor branch of the median nerve. J Hand Surg(Am)1987;12A(5):806-7. |
| 33. | Garland DE,Lucie RS, Waters RL. Current uses of open phenol nerve block
for
adult acquired spasticity. Clin Orthop 1982;165:217-22. |
| 34. | Botte MJ, Keenan MA. Brain injury and stroke. In: Gelberman RH,ed.
Operative
nerve repair and reconstruction. Philadelphia: JB Lippincott,1991:1415-51. |
| 35. | Botte MJ, Abrams RA, Bodine-Fowler SC. Treatment of acquired muscle
spasticity using phenol peripheral nerve blocks.Orthopaedics 1995;18(2):151-9. |
| 36. | Halpern D, Meelhuysen FE. Phenol motor point block in the management
of
muscular hypertonia.Arch Phys Med Rehabil 1966;47(10):659-64. |
| 37. | Halpern D, Meelhuysen FE. Duration of relaxation after intramuscular
neurolysis
with phenol. JAMA 1967;200(13):1152-4. |
| 38. | Khalili AA, Benton JG. A physiologic approach to the evaluation and
the
treatment of spasticity with procaine and phenol nerve block: including a review of the physiology of the stretch reflex. Clin Orthop 1966;47:97-104. |
| 39. | Botte MJ, Keenan MA. Percutaneous phenol blocks of the pectoralis major
muscle to treat Spastic deformities. J Hand Surg (AM)1988;13A(1):147-9. |
| 40. | Khunphasee A, Aimprasitichai S, Intharakumhang P, Phatharawarathum
S,
Theranathara K, Tosayanonda O, Khunadorn F. Phenol block in spasticity. J Thai Rehabil 1991;1(2):15-8. |
| 41. | Calderon-gonzalez R, Calderon sepulveda RF. Pathophysiology of
spasticity
and the role of botulinum toxin in its treatment. Acta Neuropediatrica 1994;1:45-57. |
| 42. | Shaari CM, George E, Wu BL, Biller HF, Sanders I. Quantifying the spread
of
botulinum toxin through muscle fascia. Larynogoscope 1991;101:960-4. |
| 43. | Lange DJ, brin MF, Warner CL, Fahn S, lovelace RE. Distant effects
of local
injection of botulinum toxin. Muscle and Nerve 1987;10:552-5. |
| 44. | Sanders DB, Massey EW, Buckley EG. Botulinum toxin for blepharospasm
:
single-fiber EMG studies. Neurology 1986;36:545-7. |
| 45. | Khunphasee A, Khunadorn F. Treatment of spasticity by phenol intramuscular
neurolysis at Pramongkutklao Hospital. J Thai Rehabil 1998;7(3): 108-114. |
| 46. | Suputtitada A . Symposium of Botulinum toxin A : Update clinical application
in
dystonia And spasticity. Medical Time 2000;2(28):S1-S4. |
| 47. | Gracies JM, Elovic E, McGuire J, Simpson DM. Traditional pharmacological
tratments for spasticity Part I : Local treatments. Muscle Nerve 1997;20 (suppl 6):S61-S91. |
| 48. | Boyd RN,Graham JEA, Nattrass GR, Graham HK. Medium-term response
characterization and risk factor analysis of botulinum toxin type A in the management of spasticity in children with cerebral palsy. Eur J Neurol 1999;6(suppl 4) : S37-45. |